Marzieh Mahmoodi

Marzieh Mahmoodi

Auto-generated profile, based on publicly available information

Marzieh Mahmoodi

Addiction and Lifestyle Research Center, Bushehr University of Medical Sciences, Bushehr, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Environmental Pollution
Verified
Journal Article
Closed access
DSDobaradaran Sina
Dobaradaran Sina
TSTorsten C. Schmidt
Torsten C. Schmidt
NLNerea Lorenzo-Parodi
Nerea Lorenzo-Parodi
MJMaik A. Jochmann
Maik A. Jochmann
INIraj Nabipour
Iraj Nabipour
MMMarzieh Mahmoodi
Marzieh Mahmoodi

1 February 2020 in Chemosphere
Verified
Journal Article
Closed access
RKRaheleh Kafaei
Raheleh Kafaei
HAHossein Arfaeinia
Hossein Arfaeinia
ASArezo Savari
Arezo Savari
MMMarzieh Mahmoodi
Marzieh Mahmoodi
MRMarzieh Rezaei
Marzieh Rezaei
BRBahman Ramavandi
Bahman Ramavandi

23 November 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
NANazi Aghaalikhani
Nazi Aghaalikhani
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh
PSPejman Shadpour
Pejman Shadpour
AAAbdolamir Abdolamir
Abdolamir Abdolamir
MMMarzieh Mahmoodi
Marzieh Mahmoodi

6 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
AMAli Movahed
Ali Movahed
PRPema Raj
Pema Raj
INIraj Nabipour
Iraj Nabipour
MMMarzieh Mahmoodi
Marzieh Mahmoodi
AOAfshin Ostovar
Afshin Ostovar
TNThomas Netticadan
Thomas Netticadan
Resveratrol has been reported to be beneficial against diabetes complications. The objective of this study was to evaluate the efficacy of resveratrol in decreasing hyperglycemia in patients with type 1 diabetes (T1D) by a preliminary investigation designed as an exploratory clinical trial. Thirteen patients with T1D from both the sexes participated in this trial. All patients received resveratrol in 500 mg capsules, twice daily for 60 days. Bodyweight, fasting blood sugar (FBS), hemoglobin A1c (HbA1c), insulin, homeostasis model of assessment for insulin resistance (HOMA-IR), homeostasis model of assessment for β-cell function (HOMA-β), and markers of liver and kidney damage, inflammation, and oxidative stress were measured before the intervention, at 30 days and at 60 days. Resveratrol supplementation for 60 days significantly decreased FBS and HbA1c in comparison with the baseline values. Resveratrol treatment also resulted in a decrease in the level of a marker for oxidative stress, malondialdehyde, and an increase in total antioxidant capacity in T1D patients. Insulin, HOMA-IR, HOMA-β, and markers of liver and kidney function and inflammation were not significantly affected by resveratrol treatment. Overall, the results showed that 60 days of resveratrol supplementation exerted strong antidiabetic and antioxidant effects in patients with T1D.

14 January 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
SBSaeid Najafpour Boushehri
Saeid Najafpour Boushehri
RKRazieh Karimbeiki
Razieh Karimbeiki
SGSara Ghasempour
Sara Ghasempour
SGSamira‐Sadat Ghalishourani
Samira‐Sadat Ghalishourani
MPMakan Pourmasoumi
Makan Pourmasoumi
FJFarahnaz Joukar
Farahnaz Joukar

15 October 2016 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
SASoheila Asadi
Soheila Asadi
MMMohammad Nabi Moradi
Mohammad Nabi Moradi
NKNejat Khyripour
Nejat Khyripour
MGMohammad Taghi Goodarzi
Mohammad Taghi Goodarzi
MMMarzieh Mahmoodi
Marzieh Mahmoodi